Skip to main content
OpenTrials

Clinical trial condition

Proteostasis Deficiencies

Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.

1,351 public trials 352 recruiting studies
Refine in advanced search Browse all conditions

Proteostasis Deficiencies trial results

Completed

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

NCT03499808

Conditions
Amorphous, Eosinophilic, and Acellular Deposit, Amyloidosis, Blood Coagulation Disorders, +40 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 345 locations
View Trial Details
Completed

A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS

NCT05357950

Conditions
ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations
  • Lawson Health Research Institute London, Ontario, Canada
  • Tel Aviv Sourasky Medical Center Tel Aviv, Israel
  • IRCCS Istituti clinici Maugeri Milan, Italy
  • A.O.U. Citta della Salute e della Scienza di Torino Torino, Italy
View Trial Details
Completed

The Care Ecosystem Consortium Effectiveness Study

NCT05669365

Conditions
Alzheimer Disease, Arterial Occlusive Diseases, Arteriosclerosis, +28 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • LA County Harbor-UCLA Medical Center Torrance, California, United States
  • University of Colorado Health Denver, Colorado, United States
  • Ochsner Medical Center New Orleans, Louisiana, United States
View Trial Details
Completed

A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)

NCT05039099

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic lateral sclerosis 1, Central Nervous System Diseases, +9 more
Locations
  • UC San Diego, ACTRI La Jolla, California, United States
  • Department of Neurology, University Hospitals Leuven, Belgium
  • ALS clinic at the Kaye Edmonton Clinic, University of Alberta Edmonton, Alberta, Canada
  • London Health Sciences Centre - Victoria Hospital London, Ontario, Canada
View all 13 locations
View Trial Details

Related conditions